Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Lanxess India upgrade...

    Lanxess India upgrade facilities in Nagda Civil Hospital

    Written by kanchan joshi joshi Published On 26 Oct 2016 5:41 AM  |  Updated On 26 Oct 2016 5:41 AM
    Lanxess India upgrade facilities in Nagda Civil Hospital
    Nagda: The German speciality chemicals firm, Lanxes India has signed a three-year long contract with a civil hospital in the district as a part of its CSR initiative. In due course of the duration agreement, the firm will be upgrading the hospital's existing facilities and infrastructure , which will provide its healthcare facilitation with more advancement to patients nearby or living in the district.

    The Chemicals business giant will be donating a state-of-the-art dialysis machine to the hospital, reported Business Standard.

    Last year Lanxes India had donated a digital X-ray machine to the civil hospital under its CSR initiative as the organization identified a still existent gap in the medical facilities provided to the locals by the hospital through a channel of demands.

    The company authorities planned the action aiming towards filling the gap as well as to lessen the dependability of the locals on medical establishments based in far-off cities like Ujjain & Indore. It was established that setting up of the dialysis machine in the Nagda Civil Hospital will ensure timely treatment at affordable costs for the local patients thereby, improving the quality of medical aid in the region.

    “At Lanxess, we have always endeavored to contribute positively to the lives of the people in Nagda and would continue to do so. We have been constantly expanding our community outreach programmes and this is one such step towards improving the quality of life of the people in the area,” stated Neelanjan Banerjee, senior executive director, Lanxess India.

    Lanxess is a speciality chemicals company with sales of Euro 7.9 billion in 2015 and about 16,700 employees in 29 countries. The company is currently represented at 55 production sites worldwide. The core business of Lanxess is the development, manufacturing and marketing of chemical intermediates, speciality chemicals and plastics.

    The company will be contributing towards the facilitation and development of the civil hospital Vis-à-vis hospital approval and demands in the coming years till its agreement comes to an end.
    CSRCSR initiativeLanxess CSR initiativeLanxess IndiamaharashtraNagda Civil HospitalNeelanjan Banerjee
    Source : With inputs

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    kanchan joshi joshi
    kanchan joshi joshi
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok